Výsledky vyhledávání - "B M, Slomovitz"

Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): A randomised, double-blind, placebo-controlled, phase 3 trial

Autor: David G. Mutch, J I Weberpals, Roberto Sabbatini, D K Armstrong, Susana Banerjee, Domenica Lorusso, Giovanni Scambia, Gottfried E. Konecny, Jonathan A. Ledermann, A Leary, T Neunhöffer, Hani Gabra, J C Goh, G Kichenadasse, R W Holloway, Iris L. Romero, Jesus Garcia-Donas, Martin Buck, Michael Friedlander, Nicoletta Colombo, Robert L. Coleman, Deborah K. Armstrong, Amnon Amit, E M Guerra, Stephen Welch, Salomon M. Stemmer, T Vanderkwaak, C Hänle, Ignace Vergote, Alain Lortholary, Laurence Gladieff, David M. O'Malley, J Garcia-Donas, A Clamp, James Sun, Andrew R Clamp, Mitch Raponi, Laurie Elit, Claudio Zamagni, R T Morris, A Casado Herraez, Y Drew, Benoit You, Thomas Harding, M Vulfovich, L Ma, B M Slomovitz, S Kovel, A Dean, C Aghajanian, Prafull Ghatage, A O'Donnell, L-m Chen, Diane Provencher, G Scambia, D M O'Malley, A El-Balat, Jeffrey C. Goh, M Leviov, Florence Joly, Ronnie Shapira-Frommer, Olivier Tredan, Marie Plante, Stefano Tamberi, Amit M. Oza, Kevin K. Lin, G E Konecny, E M Swisher, A Oaknin, I A McNeish, Johanne I Weberpals, Clare L. Scott, M Amenedo Gancedo, Paul R. Harnett, Mark A. Morgan, A Floquet, Jean-Pierre Lotz, Terri Cameron, Ana Oaknin, Elizabeth M. Swisher, Michael J. Birrer, Setsuko K. Chambers, Peter C.C. Fong, Andrew Dean, Carol Aghajanian, Sandro Pignata, Melanie E Powell, Alessandra Bologna, Caroline Grace, Christine Parkinson, C L Scott, Jeff Isaacson, J. Medioni, Heidi Giordano, Tamar Safra, H Denys, I Palacio, P C Fong, Margarita Amenedo Gancedo, Robert W Holloway, P Krabisch, N Colombo, Mary K. Buss, Alexandra Leary, Pauline Wimberger, A Sanchez, Luc Dirix, Sandra Goble, M Pölcher, Lara Maloney, Anne Floquet, D Jackson, Iain A. McNeish

Publikováno v: Lancet (London, England), vol 390, iss 10106

Background: \ud \ud Rucaparib, a poly(ADP-ribose) polymerase inhibitor, has anticancer activity in recurrent ovarian carcinoma harbouring a BRCA mutation or high percentage of genome-wide loss of heterozygosity. In this trial we assessed rucaparib ve

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0275ed6179ab07f49e1cdef255c13c2
http://hdl.handle.net/10281/171093

Zobrazit plný text záznamu

Heterogeneity of stage IIIA endometrial carcinomas: implications for adjuvant therapy

Autor: B. M. Slomovitz, L. M. Ramondetta, C. M. Lee, J. C. Oh, P. J. Eifel, A. Jhingran, T. W. Burke, D. M. Gershenson, K. H. Lu

Publikováno v: International Journal of Gynecologic Cancer. 15:510-516

The purpose of this study was to evaluate overall survival (OS) and determine prognostic subclassifications for stage IIIA endometrial cancer. Stage IIIA endometrial cancer patients treated at M.D. Anderson Cancer Center from 1989 to 2002 were review

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2df93b4f427acbb74d60b121d20bee99
https://doi.org/10.1136/ijgc-00009577-200505000-00016

Zobrazit plný text záznamu

The utility of venous lactate to triage injured patients in the trauma center

Autor: R F, Lavery, D H, Livingston, B J, Tortella, J T, Sambol, B M, Slomovitz, J H, Siegel

Publikováno v: Journal of the American College of Surgeons. 190(6)

Field triage criteria for trauma patients results in over-triage rates of 30% to 50% to achieve under-triage rates of 10%. This large number of patients may stress trauma center resources. Elevated arterial lactate (ALAC) levels have been shown to be

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f3da947e98cc6e1625efc62e02414a94
https://pubmed.ncbi.nlm.nih.gov/10873000

Zobrazit plný text záznamu